Encapsulation of Isoniazid in Chitosan-Gum Arabic and Poly (Lactic-Co-Glycolic Acid) PVA Particles to Provide a Sustained Release Formulation

Pamela Kadare, Admire Dube, Charles C. Maponga

Journal of Pharmaceutics & Pharmacology · 2015 · 22 citations · 9 references

DOIFull text

Open access

Concepts

Abstract

Background: Tuberculosis remains one of the greatest health challenges worldwide, hence the need for development of better diagnostic tools and effective treatments. Nanotechnology and particulate drug delivery systems are examples of systems which can enhance drug delivery. Isoniazid is a key pharmaceutical agent in fixed dose combination therapy for the treatment of tuberculosis. Encapsulation of isoniazid could enhance its release properties leading to reduction in frequency of dosing which has a positive impact on patient adherence to treatment.

References

9